Affimed(AFMD) - 2023 Q2 - Quarterly Report
AFMDAffimed(AFMD)2023-05-23 18:46

Exhibit 99.1 Affimed N.V. Unaudited consolidated statements of comprehensive loss (in € thousand) | --- | --- | --- | --- | |-----------------------------------------------------------------------------------------------|-------|-------------------------------------------|-----------------| | | Note | For the three months March \n2023 | ended 31 \n2022 | | Revenue | 3 | 4,510 | 8,006 | | Other income – net | | 410 | 284 | | Research and development expenses | | (29,531) | (18,379) | | General and administra ...